SCHEMBL7661748

SCHEMBL7661748

COC[C@H]1O[C@H](Oc2ccc(N)cc2)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.44
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7661744 1.00 TYR (0.54) TYRTDP1POLB
SCHEMBL7654601 0.88 TYR (0.44) TYRTDP1POLB
SCHEMBL7660091 0.88 TYR (0.41) TYRTDP1
SCHEMBL7660621 0.88 TYR (0.41) TYRTDP1
SCHEMBL7654608 0.88 TYR (0.44) TYRTDP1POLB
SCHEMBL7660617 0.88 TYR (0.41) TYRTDP1
SCHEMBL7660083 0.88 TYR (0.41) TYRTDP1
SCHEMBL6009966 0.85 TYR (0.52) TYRPOLB
SCHEMBL7796014 0.85 TYR (0.38) TYR
SCHEMBL7662322 0.85 TYR (0.44) TYRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492335-B1 Glycoconjugates from modified camptothecin derivatives (20-O-linkage) BAYER AKTIENGESELLSCHAFT (DE) 2002-12-10 — — US disclosed
EP-0934329-B1 GLYCOCONJUGATES FROM MODIFIED CAMPTOTHECIN DERIVATES (20-O-LINKAGE) BAYER AG (DE) 2001-12-12 — — EP disclosed
EP-0939765-B1 GLYCOCONJUGATES OF MODIFIED CAMPTOTHECIN DERIVATIVES (A- OR B-RING LINKAGE) BAYER AG (DE) 2001-12-05 — — EP disclosed
US-6271342-B1 SERUM STABILITY; FOR TUMOR THERAPY BAYER AKTIENGESELLSCHAFT (DE) 2001-08-07 — — US disclosed
US-6156754-A Glycoconjugates of modified camptothecin derivatives (A-or B-ring linkage) BAYER AKTIENGESELLSCHAFT (DE) 2000-12-05 — — US disclosed
EP-0819135-B1 SUGAR-MODIFIED CYTOSTATICS BAYER AG (DE) 1999-11-17 — — EP disclosed
CN-1185786-A Sugar-modified cytostatics BAYER AG (DE) 1998-06-24 — — CN disclosed
Send feedback